Abstract
Purpose
Leishmaniasis comprises various clinical forms mainly including cutaneous, muco-cutaneous, and visceral leishmaniasis; caused by Leishmania species. Antimoniate is the first-line treatment but some cases showed no response to treatment in the worldwide. In this study, mitogen-activated protein kinase (MAPK) and aquaglyceroporin 1 (AQP1) gene expressions were assessed in treatment failure clinical isolates of Leishmania major. Also, molecular and phylogenic analyses of the mentioned isolates were performed.
Methods
Samples were obtained from the patients with suspicious CL referred to the laboratory of Diagnosis Center, Gorgan Province, Iran, from October 2016 to December 2019. Detection and identification of the parasite was performed. The genes expressions of MAPK1 and AQP1 were done using SYBR Green real-time PCR. The AQP1 gene from the isolates with treatment failure was sequenced and analyzed using BLAST and multiple alignments. The phylogenic analysis was done using MEGA7. The statistical analysis was done using SPSS 16.0 by non-parametric Mann–Whitney U test.
Results
All clinical isolates were detected L. major. The mean AQP1 and MAPK1 gene expressions in treatment failure isolates were 58.71 and 6.139 fold less than the ones in treatment response isolates, respectively. Based on the AQP1 gene sequence, a nucleotide change of aspartic acid with asparagine at the site 234 was observed. Phylogenic tree analysis showed three groups with the minimum dissimilarity of 0.008 between TF isolates with the standard L. major strains.
Conclusion
We showed that MAPK1 and AQP1 may have critical roles in response to antimoniate in clinical isolates L. major in this study.
Similar content being viewed by others
Availability of data and materials
All data generated or analyzed during this study are available by the corresponding author.
Code availability
Not applicable.
References
Alvar J, Aparicio P, Aseffa A, Den Boer M, Cañavate C, Dedet JP, Gradoni L, Ter Horst R, López-Vélez R, Moreno J (2008) The relationship between leishmaniasis and AIDS: the second 10 years. Clin Microbiol Rev 21:334–359. https://doi.org/10.1128/CMR.00061-07
Alvar J, Vélez ID, Bern C, Herrero M, Desjeux P, Cano J, Jannin J, den Boer J, WHO Leishmaniasis Control Team (2012) Leishmaniasis worldwide and global estimates of its incidence. PLoS ONE 7:e35671. https://doi.org/10.1371/journal.pone.0035671
Torres-Guerrero E, Quintanilla-Cedillo MR, Ruiz-Esmenjaud J, Arenas R (2017) Leishmaniasis: a review. F1000Rres 6:750–750. https://doi.org/10.12688/f1000research.11120.1
Hejazi H, Eslami G, Dalimi A (2004) The parasiticidal effect of electricity on Leishmania major, both in vitro and in vivo. Ann Trop Med Parasitol 98:37–42. https://doi.org/10.1179/136485913X13789813917661
Machado-Silva A, Guimarães PP, Tavares CA, Sinisterra RD (2015) New perspectives for leishmaniasis chemotherapy over current anti-leishmanial drugs: a patent landscape. Expert Opin Ther Pat 25:247–260. https://doi.org/10.1517/13543776.2014.993969
Abtahi M, Eslami G, Cavallero S, Vakili M, Hosseini SS, Ahmadian S, Boozhmehrani MJ, Khamesipour A (2020) Relationship of Leishmania RNA Virus (LRV) and treatment failure in clinical isolates of Leishmania major. BMC Res Notes 13:126. https://doi.org/10.1186/s13104-020-04973-y
Alijani Y, Hosseini SS, Ahmadian S, Boughattas S, Eslami G, Naderian S, Ajamein V (2019) Molecular analysis of Aquaglyceroporin 1 gene in non-healing clinical isolates obtained from patients with cutaneous Leishmaniasis from Central of Iran. J Arthropod Borne Dis 13:145–152. https://doi.org/10.18502/jad.v13i2.1240
Eslami G, Hatefi S, Ramezani V, Tohidfar M, Churkina TV, Orlov YL, Hosseini SS, Boozhmehrani MJ, Vakili M (2021) Molecular characteristic of treatment failure clinical isolates of Leishmania major. PeerJ 9:e10969. https://doi.org/10.7717/peerj.10969
Hindley A, Kolch W (2002) Extracellular signal regulated kinase (ERK)/mitogen activated protein kinase (MAPK)-independent functions of Raf kinases. J Cell Sci 115(8):1575–1581. https://doi.org/10.1242/jcs.115.8.1575
Mandal G, Sharma M, Kruse M, Sander-Juelch C, Munro LA, Wang Y, Vilg JV, Tamás MJ, Bhattacharjee H, Wiese M, Mukhopadhyay R (2012) Modulation of Leishmania major aquaglyceroporin activity by a mitogen-activated protein kinase. Mol Microbiol 85:1204–1218. https://doi.org/10.1111/j.1365-2958.2012.08169.x
Figarella K, Uzcategui NL, Zhou Y, Lefurgey A, Ouellette M, Bhattacharjee H, Mukhopadhyay R (2007) Biochemical characterization of Leishmania major aquaglyceroporin LmAQP1: possible role in volume regulation and osmotaxis. Mol Microbiol 65:1006–1017. https://doi.org/10.1111/j.1365-2958.2007.05845.x
Marquis N, Gourbal B, Rosen BP, Mukhopadhyay R, Ouellette M (2005) Modulation in aquaglyceroporin AQP1 gene transcript levels in drug-resistant Leishmania. Mol Microbiol 57:1690–1699. https://doi.org/10.1111/j.1365-2958.2005.04782.x
Martínez DY, Llanos-Cuentas A, Dujardin JC, Polman K, Adaui V, Boelaert M, Verdonck K (2020) A case-control study on the association between intestinal helminth infections and treatment failure in patients with cutaneous leishmaniasis. Open Forum Infect Dis 7:ofaa155. https://doi.org/10.1093/ofid/ofaa155
Eslami G, Salehi R, Khosravi S, Doudi M (2012) Genetic analysis of clinical isolates of Leishmania major from Isfahan, Iran. J Vector Borne Dis 49:168–174
Eslami G, Zarchi MV, Moradi A, Hejazi SH, Sohrevardi SM, Vakili M, Khamesipour A (2016) Aquaglyceroporin1 gene expression in antimony resistance and susceptible Leishmania major isolates. J Vector Borne Dis 53:370–374
Hoffert JD, Leitch V, Agre P, King LS (2000) Hypertonic induction of aquaporin-5 expression through an ERK-dependent pathway. J Biol Chem 275:9070–9077. https://doi.org/10.1074/jbc.275.12.9070
Arima H, Yamamoto N, Sobue K, Umenishi F, Tada T, Katsuya H, Asai K (2003) Hyperosmolar mannitol simulates expression of aquaporins 4 and 9 through a p38 mitogen-activated protein kinase-dependent pathway in rat astrocytes. J Biol Chem 278:44525–44534. https://doi.org/10.1074/jbc.M304368200
Thorsen M, Di Y, Tängemo C, Morillas M, Ahmadpour D, Van der Does C, Wagner A, Johansson E, Boman J, Posas F, Wysocki R, Tamás MJ (2006) The MAPK Hog1p modulates Fps1p-dependent arsenite uptake and tolerance in yeast. Mol Biol Cell 17:4400–4410. https://doi.org/10.1091/mbc.E06-04-0315
Uzcategui NL, Zhou Y, Figarella K, Ye J, Mukhopadhyay R, Bhattacharjee H (2008) Alteration in glycerol and metalloid permeability by a single mutation in the extracellular C-loop of Leishmania major aquaglyceroporin LmAQP1. Mol Microbiol 70:1477–1486. https://doi.org/10.1111/j.1365-2958.2008.06494.x
Ishibashi K, Morishita Y, Tanaka Y (2017) The evolutionary aspects of aquaporin family. Adv Exp Med Biol 969:35–50. https://doi.org/10.1007/978-94-024-1057-0_2
Wree D, Wu B, Zeuthen T, Beitz E (2011) Requirement for asparagine in the aquaporin NPA sequence signature motifs for cation exclusion. FEBS J 278:740–748. https://doi.org/10.1111/j.1742-4658.2010.07993.x
Wu B, Steinbronn C, Alsterfjord M, Zeuthen T, Beitz E (2009) Concerted action of two cation filters in the aquaporin water channel. EMBO J 28:2188–2194. https://doi.org/10.1038/emboj.2009.182
Ishibashi K, Koike S, Kondo S, Hara S, Tanaka Y (2009) The role of a group III AQP, AQP11 in intracellular organelle homeostasis. J Med Investig 56(Suppl):312–317. https://doi.org/10.2152/jmi.56.312
Kaur P, Anand A, Bhat A, Maras JS, Goyal N (2021) Comparative phosphoproteomic analysis unravels MAPK1 regulated phosphoproteins in Leishmaniadonovani. J Proteom 240:104189. https://doi.org/10.1016/j.jprot.2021.104189
Raj S, Saha G, Sasidharan S, Dubey VK, Saudagar P (2019) Biochemical characterization and chemical validation of Leishmania MAP Kinase-3 as a potential drug target. Sci Rep 9:16209. https://doi.org/10.1038/s41598-019-52774-6
Baker N, Catta-Preta CMC, Neish R, Sadlova J, Powell B, Alves-Ferreira EVC, Geoghegan V, Carnielli JBT, Newling K, Hughes C, Vojtkova B, Anand J, Mihut A, Walrad PB, Wilson LG, Pitchford JW, Volf P, Mottram JC (2021) Systematic functional analysis of Leishmania protein kinases identifies regulators of differentiation or survival. Nat Commun 12:1244. https://doi.org/10.1038/s41467-021-21360-8
Acknowledgements
This research was done by Research Center of Food Hygiene and Safety, Shahid Sadoughi University of Medical Sciences, Yazd, Iran. We sincerely thank the technical supports of the staff of Research Center of Food Hygiene and Safety, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Funding
This research was financially supported by Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Author information
Authors and Affiliations
Contributions
Data collection, doing the experiments (RS); study design, supervising the method, critical revising the manuscript: (GE); statistical analysis: (MV). All authors read the manuscript.
Corresponding author
Ethics declarations
Conflict of Interest
There is no conflict of interest.
Ethical approval
This study was approved by Ethics ID of IR.SSU.MEDICINE.REC.1395.335 by the Ethical Committee of Shahid Sadoughi University of Medical Sciences, Yazd, Iran. All patients wrote and signed the informed consent form prior to including in this study.
Consent to participate
The informed consent was written and completed by each patient participating in this study before recording the information and sampling based on Helsinki declaration.
Consent for publication
The consent form was completed with the patients.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Somee, R., Eslami, G. & Vakili, M. Mitogen-Activated Protein Kinase and Aquaglyceroporin Gene Expression in Treatment Failure Leishmania major. Acta Parasit. 67, 309–315 (2022). https://doi.org/10.1007/s11686-021-00463-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11686-021-00463-8